Every year, one of the “can’t miss” oncology events on LEAP’s calendar is the American Society of Clinical Oncology (ASCO) meeting in Chicago. From 5/30-6/3, ASCO 2025 is the place to discover what’s next on the cutting edge of clinical oncology and forge partnerships that have the power to change the landscape of cancer care.

This year, we’re especially looking forward to panels on the expanded use of MRD testing for patient management. We’ve been helping oncology labs, both large and small, by implementing solutions that enable quick onboarding of these tests with seamless integration into the EHR.

Is your lab expanding access to measurable residual disease (MRD) testing? If you’re attending ASCO, why not meet with Heather Williams, PhD, MBA, MS, PGD, ERCLG, CG(ASCP)MB, Practice Principal of Life Sciences at Leap Consulting Group, to discover how we can help you streamline the process of supporting your patients? Contact us and let’s talk about how we can help you get your patients the right tests at the right time.

You can find out more about ASCO 2025, including the panels on MRD testing, here: https://www.asco.org/annual-meeting

‍